Organized by the Faculty of Medicine and Lille University Hospital.
Under the auspices of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), The Société Française de lute contre les Cancers et les leucémies de l’Enfant et de l’adolescent (SFCE), The Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), The Intergroup Francophone du Myélome (IFM), and The Lymphoma Study Association (LYSA).
Faculté de Médecine – pôle recherche
1 place de Verdun 59000 Lille France
The 6th French International Symposium on CAR T-cell therapy « CARTday» is taking place in Lille, France on September 7-9, 2022. This meeting aims to gather the most preeminent and emerging international leaders in the field of cellular immunotherapy. The meeting will focus on cellular immunotherapy and cover a range of topics, including natural basis of synthetic CAR-T immunotherapy, lessons learned from targeting B cell malignancies, challenges and road ahead, therapeutic use of cytokines in the context of CART therapy, nature killer cell-based immunotherapy, manufacturing CART cells and implementation of CAR T-cell therapy in an academic setting. In addition, the program will bring you all the latest reported data in CAR T-cell therapy.
This meeting is organized by the Lille University Hospital and Faculty of Medicine and this year, it is going to extend its collaboration network, to include, besides the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)), a diversity of cooperative groups in France whose main focus is CAR T cells, including The Société Française de lute contre les Cancers et les leucémies de l’Enfant et de l’adolescent, The Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), The Intergroup Francophone du Myélome (IFM), and The Lymphoma Study Association (LYSA). Like the last years, we expect getting-together a large number of participants during this day of intense and hopefully highly productive exchanges. The meeting is designed to provide an excellent platform for networking between clinicians, scientists, and other stakeholders in the field.
Hopefully the COVID-19 pandemic will be ended by the time of the meeting which will be in person. However, decision can be made in June if there is a need to have it hybrid with streaming live should you not be able to physically attend.
The target audience is all individual encolved in the CAR T-cell therapy including hematologists, oncologists, physicians, pharmacists, scientists, nurses, data managers and supply chain managers.
Bertrand Arnulf (IFM), Emmanuel Bachy (Lysa), André Baruchel (SFCE), Jacques-Olivier Bay (SFGM-TC), Gandhi Damaj (Lysa), Nicolas Boissel (GRAALL), Olivier Boyer (Rouen), Christophe Ferrand (Besançon), Camille Giverne (Rouen), Salomon Manier (IFM), Chrystel Marton (Lille), Suman Mitra (Lille), Franck Morschhauser (Lysa), Stéphanie Nguyen (SFGM-TC), Ibrahim Yakoub-Agha (Lille),